197 related articles for article (PubMed ID: 10697069)
21. Correspondence (letter to the editor): Is the treatment the problem?
Dietrich K
Dtsch Arztebl Int; 2010 Dec; 107(51-52):918. PubMed ID: 21249139
[No Abstract] [Full Text] [Related]
22. Politics vs practice: commentary on the ADHD debate.
Levy F
Aust N Z J Psychiatry; 2013 Jan; 47(1):89-91. PubMed ID: 23293313
[No Abstract] [Full Text] [Related]
23. The difference between efficacy and effectiveness research in studying attention-deficit/hyperactivity disorder.
Wolraich ML
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1220-1. PubMed ID: 10591296
[No Abstract] [Full Text] [Related]
24. Use of medication in children with psychiatric disorders.
Barton R
Community Pract; 2007 Nov; 80(11):42, 44. PubMed ID: 18064853
[TBL] [Abstract][Full Text] [Related]
25. Management of psychopharmacologic agents in children and adolescents.
Carlson GA; Ranade L; Qadir A
Psychiatr Q; 1992; 63(4):391-411. PubMed ID: 1361998
[No Abstract] [Full Text] [Related]
26. ADHD debate clouded by preconceptions and undisclosed conflicts of interest.
Whitely M
Aust N Z J Psychiatry; 2013 Oct; 47(10):956-8. PubMed ID: 23888076
[No Abstract] [Full Text] [Related]
27. The ADHD debate: to bury national guidelines or to praise them?
Paterson R
Aust N Z J Psychiatry; 2013 Oct; 47(10):959-60. PubMed ID: 23888074
[No Abstract] [Full Text] [Related]
28. Commentary on Levy (2012) politics vs practice: withdrawal of the draft NHMRC ADHD guidelines.
Starling J
Aust N Z J Psychiatry; 2013 Jan; 47(1):91-2. PubMed ID: 23293314
[No Abstract] [Full Text] [Related]
29. ADHD in Western Australia: an iatrogenic 'epidemic' cured by bureaucracy? Time to focus on the facts.
Paterson R
Aust N Z J Psychiatry; 2013 Jan; 47(1):88-9. PubMed ID: 23293312
[No Abstract] [Full Text] [Related]
30. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
[TBL] [Abstract][Full Text] [Related]
31. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.
Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S
Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886
[TBL] [Abstract][Full Text] [Related]
32. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S;
J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2 Suppl):26S-49S. PubMed ID: 11833633
[TBL] [Abstract][Full Text] [Related]
33. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
[TBL] [Abstract][Full Text] [Related]
34. Treatment of attention-deficit/hyperactivity disorder.
Breggin PR
JAMA; 1999 Apr; 281(16):1490-1; author reply 1491. PubMed ID: 10227316
[No Abstract] [Full Text] [Related]
35. The use of health care services and psychotropic medication in a community sample of 9-year-old schoolchildren with ADHD.
Tremmery S; Buitelaar JK; Steyaert J; Molenberghs G; Feron FJ; Kalff AC; Hurks PP; Hendriksen JG; Vles JS; Jolles J
Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):327-36. PubMed ID: 17636356
[TBL] [Abstract][Full Text] [Related]
36. Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK.
Hsia Y; Maclennan K
Eur J Epidemiol; 2009; 24(4):211-6. PubMed ID: 19266290
[TBL] [Abstract][Full Text] [Related]
37. Use, abuse, toxicity, and monitoring of pediatric psychotropic drug therapy: new issues for the new millennium.
Liebelt EL
Curr Opin Pediatr; 2002 Apr; 14(2):211-2. PubMed ID: 11981292
[No Abstract] [Full Text] [Related]
38. World wide use of psychotropic drugs in child and adolescent psychiatric disorders.
Simeon JG; Wiggins DM; Williams E
Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):455-65. PubMed ID: 7624496
[TBL] [Abstract][Full Text] [Related]
39. Stimulating: prescribing amidst controversy.
Martin A
Am J Psychiatry; 2006 Apr; 163(4):574-7. PubMed ID: 16585428
[No Abstract] [Full Text] [Related]
40. ADHD Medication Trends in Turkey: 2009-2013.
Öner Ö; Yilmaz EŞ; Karadağ H; Vural M; Vural EH; Akbulat A; Gürsöz H; Türkçapar H; Kerman S
J Atten Disord; 2017 Dec; 21(14):1192-1197. PubMed ID: 24554298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
